It should be stressed that secondary modulation of dopaminergic and serotonergic transmission by BDNF represents one mechanism affecting anxiety, depression, and schizophrenia as previously described mechanisms such as neuroinflammation, oxidative stress, and plasticity impairments are also involved and modulated by BDNF. The gene discussed is BDNF; the disease is major depressive disorder.